Skip to main content
Clinical Trials/CTRI/2023/09/057533
CTRI/2023/09/057533Not yet recruitingPhase 3

A Comparative Pharmaceutical- Analytical Study of Traditional & Advanced Dosage Form of Raktachandanadi Lepa with Mukta Bhasma and its Clinical Effects in Vyanga. - Nil

Government PG Ayurvedic College And Hospital Varanasi0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Patients suffering from classical clinical signs and symptoms of Vyanga–
  • 1. Mukhamaagatya mandalam i.e. Circumscribed patches over face.
  • 2. Tanukam i.e. Unelevated pigmentation of the facial skin.
  • 3. Shyavam i.e. Dark brown pigmentation of the facial skin.
  • 4. Neerujam i.e. Painless patches.

Exclusion Criteria

  • Patients having pigmentation other than the face and other Kshudraroga.
  • Pigmentation produced due to side effects of any other drug applied earlier.
  • Patients below 15 years and above 45 years.
  • Individuals suffering from systemic pathologies like SLE, Cancer, Severe Hormonal imbalance etc.
  • Patients on medication of Hormonal Therapy.
  • Pregnant or Breastfeeding mother.
  • Patients having complains of painful pigmented patches.

Investigators

Sponsor
Government PG Ayurvedic College And Hospital Varanasi

Similar Trials

Formation of Raktachandanadi Lepa and... | Clinical Trial